Anti-malaria benefit of hydroxyurea in SCA, IL-22 in the treatment in lower GI acute GVHD, and FLT3-ITD changes depend on context in AML
This episode reviews research on hydroxyurea potentially lowering malaria incidence in sickle cell anemia patients, the efficacy and tolerance of IL-22 therapy for lower GI acute GVHD, and how FLT3-ITD mutations in AML create distinct contexts influencing therapeutic…